News
Public · Published
Sensata Technologies (ST) Posts Q3 Results, Guides Q4 Revenue $942M–$972M
Sensata Technologies reported third-quarter 2026 results and guided fourth-quarter 2026 revenue to $942 million to $972 million, with adjusted earnings per share of $0.95 to $0.99. The guidance includes tariff cost recovery, which may involve one-time effects.
Published:
Updated:
What happened
Sensata Technologies reported third-quarter 2026 results and guided fourth-quarter 2026 revenue to $942 million to $972 million, with adjusted earnings per share of $0.95 to $0.99. The guidance includes tariff cost recovery, which may involve one-time effects.
Confirmed
Global impact / market context
The fourth-quarter revenue and adjusted earnings per share guidance sets near-term sales and profit expectations that investors will compare with consensus estimates. Because the guidance includes tariff cost recovery, which means recovering import tax costs, reported revenue may include one-time effects that could overstate underlying growth.
Analyst inference
This is a routine earnings print with forward guidance, offering mid-cycle clarity after a 2025 segment reorganization. A share price catalyst would require third-quarter details showing performance versus expectations and fourth-quarter guidance compared with consensus, plus commentary on tariff recoveries and organic growth.
Analyst inference
What to watch
- Fourth-quarter revenue guidance is $942 million to $972 million and adjusted earnings per share guidance is $0.95 to $0.99, which investors will compare with consensus estimates. Confirmed
- Analysts should separate organic growth from tariff cost recovery, which means recovering import tax costs, because one-time effects may inflate revenue and make the quality of any beat unclear. Proposed
- Commentary on the earnings call about third-quarter details and tariff recoveries could shift investor positioning in Sensata shares, since guidance versus consensus and organic growth drive the near-term catalyst. Analyst inference
Evidence
- Original source link unavailable